Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03846986 · ClinicalTrials.gov registry record · NA
Postprandial Glycemia in Apple Products
A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03846986: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT03846986 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03846986, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The primary objective of the study is to compare the effects of a whole apple, apple juice alone, and apple juice with pomace on 2 hr glycemic response as measured by maximal glucose concentration
Primary Outcome
Plasma Glucose maximal concentration (Cmax) over 2 hours
Interventions
- DIETARY_SUPPLEMENT Apple Juice1
- DIETARY_SUPPLEMENT Apple Juice2
- DIETARY_SUPPLEMENT Raw Apple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2020-06-12 |
| Phase | NA |
What the finished NCT03846986 record still lists
NCT03846986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Apple Juice1 is the first listed.
NCT03846986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03846986 about?
NCT03846986 is a clinical study titled "Postprandial Glycemia in Apple Products". The primary objective of the study is to compare the effects of a whole apple, apple juice alone, and apple juice with pomace on 2 hr glycemic response as measured by maximal glucose concentration
What is the current status of trial NCT03846986?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2019-02-28. Estimated completion is 2020-06-12.
What interventions are being tested in trial NCT03846986?
The interventions under investigation include: Apple Juice1 (DIETARY_SUPPLEMENT), Apple Juice2 (DIETARY_SUPPLEMENT), Raw Apple (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03846986?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03846986's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI